Oncology Nursing News
Articles
Oncology Nursing News Top Stories: January 2023
February 01, 2023
Article
Each month, Oncology Nursing News® takes a look back at our most popular stories.
FDA Approves Zanubrutinib for CLL/SLL
January 19, 2023
Article
The FDA has approved zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The prescribing label comes with warnings for hemorrhage, infections, cytopenias, second primary malignancies, and cardiac arrythmias.
A Look Back at 2022 FDA Approvals in Oncology
January 02, 2023
Podcast
In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.
Oncology Nursing News: Top Stories from 2022
December 31, 2022
Article
Thank you for reading Oncology Nursing News® in 2022. We look forward to bringing you more news in 2023.
Oncology Nursing News Top Stories: November 2022
November 30, 2022
Article
In November 2022, HER2-directed therapies made headlines in breast cancer as did innovations to help individuals who are often overlooked in oncology care.
Oncology APPs, Research Nurses Are Uniquely Poised to Tackle irAE Management in Follicular Lymphoma
July 20, 2022
Article
Because immune-related adverse events can be hard to diagnose, patient education and clear avenues of communication with an oncology care team are critical, according to investigators at the 2022 Pan Pacific Lymphoma Conference.
Investigators Unveil Real-World Experiences on Shared Decision-Making in R/R DLBCL
July 19, 2022
Article
The ideal model for promoting effective shared decision-making involves tailored caregiver education, adequate time before treatment, and use of multidisciplinary support.
Oncology Nursing News Top Stories: June 2022
June 30, 2022
Article
Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from June 2022.
ONS Annual Congress Focuses on Increasing Nurse Comfort and Patient Understanding in Cancer Care
June 24, 2022
Article
This year’s congress showcased strategies for communicating sensitive topics, patient experiences with immunotherapy treatments, updates in the utility of medical cannabis, and more.
A Quick Look at the 2022 AACR Annual Meeting
June 23, 2022
Article
This year’s conference highlighted advances in natural killer cells, CD39 and KRAS G12C inhibitors, and CAR T-cell therapies.